AIA Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.5M Buy
189,914
+31,842
+20% +$1.86M 0.17% 89
2025
Q4
$8.53M Buy
158,072
+34,901
+28% +$1.68M 0.13% 111
2025
Q3
$5.56M Sell
123,171
-4,819
-4% -$225K 0.1% 132
2025
Q2
$5.92M Buy
127,990
+33,388
+35% +$1.64M 0.13% 92
2025
Q1
$5.77M Buy
94,602
+70,858
+298% +$4.13M 0.14% 80
2024
Q4
$1.34M Buy
23,744
+925
+4% +$51.7K 0.03% 185
2024
Q3
$1.18M Sell
22,819
-19,862
-47% -$932K 0.03% 206
2024
Q2
$1.77M Sell
42,681
-45,087
-51% -$2.02M 0.05% 159
2024
Q1
$4.76M Buy
87,768
+31,792
+57% +$1.62M 0.16% 68
2023
Q4
$2.87M Buy
55,976
+7,290
+15% +$383K 0.12% 86
2023
Q3
$2.83M Buy
48,686
+8,764
+22% +$537K 0.14% 82
2023
Q2
$2.55M Buy
39,922
+9,490
+31% +$636K 0.12% 81
2023
Q1
$2.11M Sell
30,432
-802
-3% -$56.6K 0.11% 82
2022
Q4
$2.25M Sell
31,234
-35,388
-53% -$2.67M 0.14% 65
2022
Q3
$4.74M Buy
66,622
+25,468
+62% +$1.85M 0.31% 36
2022
Q2
$3.17M Buy
41,154
+6,753
+20% +$514K 0.17% 56
2022
Q1
$2.51M Buy
34,401
+21,122
+159% +$1.42M 0.11% 86
2021
Q4
$828K Sell
13,279
-73,689
-85% -$4.32M 0.04% 148
2021
Q3
$5.15M Buy
86,968
+61,982
+248% +$4.08M 0.29% 57
2021
Q2
$1.66M Buy
24,986
+12,727
+104% +$830K 0.11% 88
2021
Q1
$774K Buy
+12,259
New +$763K 0.11% 95

Other funds holding BMY

AIA Group's BMY Position: Q1 2026 in Review

AIA Group increased its Bristol-Myers Squibb (BMY) stake by 20% in Q1 2026, buying an estimated $1.86M and bringing the position to 189,914 shares worth $11.5M. The position accounts for 0.17% of the portfolio, ranked #89.

AIA Group first reported a position in BMY in Q1 2021 and has held it in 21 quarters since. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • AIA Group held 189,914 shares of Bristol-Myers Squibb worth $11.5M as of Q1 2026.
  • AIA Group bought 31,842 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.86M.
  • Bristol-Myers Squibb made up 0.17% of AIA Group's portfolio in Q1 2026, its #89 holding.
  • AIA Group first reported a position in Bristol-Myers Squibb in Q1 2021 and has held it in 21 quarters since.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on AIA Group's 13F filing for Q1 2026, filed 6 May 2026.